Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chicago Rivet & Machine Co. Common Stock (NY:CVR)

14.05 +0.14 (+1.01%)
Streaming Delayed Price Updated: 9:30 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chicago Rivet & Machine Co. Common Stock

News headline image
12 Industrials Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Industrials Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Chicago Rivet & Machine's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Thriving with Robust Performance: Chicago Rivet & Machine Delivers Growing Profits to Investors ↗
 
Via Benzinga
News headline image
Chicago Rivet & Machine's Ex-Dividend Date Is Friday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
CVR Stock Earnings: Chicago Rivet & Machine Reported Results for Q2 2024 ↗
Chicago Rivet & Machine just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
CVR Stock Earnings: Chicago Rivet & Machine Reported Results for Q1 2024 ↗
Chicago Rivet & Machine just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
CVR Stock Earnings: Chicago Rivet & Machine Reported Results for Q4 2023 ↗
Chicago Rivet & Machine just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Friday Is Your Last Chance To Buy Chicago Rivet & Machine Before The Dividend Payout ↗
 
Via Benzinga
News headline image
Dividends By The Numbers In August 2023 ↗
August 2023's dividend metadata continues to provide evidence of what might best be described as a slow-motion recovery from the U.S. stock market's 2022 earnings recession. 
Via Talk Markets
5 Value Stocks In The Industrials Sector ↗
 
Via Benzinga
Chicago Rivet & Machine's Ex-Dividend Date Is Friday, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Chicago Rivet & Machine: Dividend Insights ↗
Thursday marks the last chance for investors to receive the next dividend payout from Chicago Rivet & Machine (AMEX:CVR). 
Via Benzinga
News headline image
7 Dividend Stocks That Are Screaming Buys Right Now: July 2023 ↗
With economic uncertainty weighing on Wall Street, concerned investors may want to consider these dividend stocks to buy. 
Via InvestorPlace
News headline image
7 Names to Buy as Stock Market Crash Fears Fester ↗
With a downturn representing a non-zero probability, investors should start thinking about these stocks to buy before crash. 
Via InvestorPlace
News headline image
The 7 Best Bargain Stocks to Buy for May 2023 ↗
With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly. 
Via InvestorPlace
News headline image
12 Industrials Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
5 Value Stocks In The Industrials Sector ↗
 
Via Benzinga
News headline image
7 Dividend-Paying Industrial Stocks for 2023 for Your Buy List ↗
While not the most exciting sector available, dividend-paying industrial stocks to buy offer significant stability amid the ambiguities. 
Via InvestorPlace
News headline image
This Billionaire Made Bank, Boasts A 30% Return Despite 2022's Market Crash ↗
Billionaire Carl Icahn saw the net asset value of Icahn Enterprises (NASDAQ: IEP) increase by nearly 30% in the first six months 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.